| Literature DB >> 6134650 |
P E Lins, A Wajngot, U Adamson, M Vranic, S Efendić.
Abstract
In man a small dose of somatostatin (50 micrograms/h) suppressed moderately basal insulin (5 microU/ml) and glucagon (40 pg/ml) levels. This resulted in a short-lasting hypoglycemia, which was then followed by marginal hyperglycemia throughout the experiment. The addition of a minimal dose of glucagon (0.50 ng/kg/min) to somatostatin normalized basal glucagon levels and resulted in a significant and sustained hyperglycemia. During the first 2 h, hyperglycemia was mainly due to increased glucose production, whereas later on it was maintained by decreased glucose uptake. We conclude that, in man moderately deprived of insulin, even a marginal change in glucagon level induces a long-lasting hyperglycemia.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6134650 DOI: 10.2337/diab.32.7.633
Source DB: PubMed Journal: Diabetes ISSN: 0012-1797 Impact factor: 9.461